Browsing by Author "Kıvanç, Demet"
Now showing items 1-4 of 4
-
Comparison of outcomes of total body irradiation (TBI) vs non-TBI conditioning regimens in acute lymphoblastic leukemia for allogeneic transplantation
Beköz, Hüseyin Saffet; Sevindik, Ömür Gökmen; Özçelik, Tülay; Arat, Mutlu; Hindilerden, İpek Yonal; Beşışık, Sevgi Kalayoğlu; Nalcacı, Meliha; Uzay, Ant; Kartı, Süleyman Sami; Kıvanç, Demet; Sargın, Deniz (Nature Publishing Group, 2019)... -
Genetic polymorphisms in 15 STR loci in the Turkish population living in İstanbul province
Özdilli, Kürşat; Duvarcı Öğret, Yeliz; Oğuz, Rüştü; İşsever, Halim; Yokeş, Mehmet Baki; Şentürk Çiftci, Hayriye; Abatay Sel, Figen; Kıvanç, Demet; Kekik Çınar, Çiğdem; Pehlivan, Sacide; Savran Oğuz, Fatma (Nobelmedicus, 2022)Objective: Short tandem repeats (STRs) are short sequences of nucleotides that are repeated and distributed all over the genome. These polymorphisms enable investigation of the forensic, ancestral lineage and evolutionary ... -
Impact of HLA-DPB1 matching in unrelated allogeneic atem cell transplantation: Results of two centers from Turkey
Kantarcıoğlu, Bülent; Beköz, Hüseyin Saffet; Hindilerden, İpek Y.; Kıvanç, Demet; Öğret, Yeliz D.; Kalayoğlu Beşışık, Sevgi; Savran Oğuz, Fatma; Sargın, Deniz (Akad Doktorlar Yayınevi, 2017)In this study, we retrospectively examined 34 donor/recipient transplant pairs fully tested for the alleles HLA-A, B, C, DRB1, DQB1 and DPB1 in two different centers in Istanbul, Turkey. HLA-DPB1 disparity in at least one ... -
Isolated extramedullary cutaneous relapse despite concomitant severe graft-vs.-host disease and tissue chimerism analysis in a patient with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: A case report
Kantarcıoğlu, Bülent; Beköz, Hüseyin Saffet; Duvarcı Öğret, Yeliz; Çakır, Aslı; Kıvanç, Demet; Oğuz Savran, Fatma; Sargın, Deniz (Spandidos Publ Ltd., 2016)Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment option for patients with acute lymphoblastic leukemia (ALL). The curative potential of allo-HSCT for ALL is, in part, due ...
